Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Leukemia|December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Pérez-García, S Brunet, J J Berlanga, et al.Molecular Marine Biology and Biotechnology|March 1, 1996
Growth enhancement in transgenic tilapia by ectopic expression of tilapia growth hormoneR Martínez, M P Estrada, J Berlanga, et al.Bone Marrow Transplantation|November 1, 1996
Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemiaC Boqué, J Petit, J Sarrá, et al.Leukemia|January 17, 2003
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cellsL Muñoz, J F Nomdedéu, N Villamor, et al.Annals of Neurology|December 23, 2011
Rare variants in the CYP27B1 gene are associated with multiple sclerosisSreeram V Ramagopalan, David A Dyment, M Zameel Cader, et al.Bone Marrow Transplantation|January 9, 1998
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseD Gallardo, J García-López, A Sureda, et al.Genome Research|August 26, 2010
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolutionSreeram V Ramagopalan, Andreas Heger, Antonio J Berlanga, et al.Gene|September 2, 2019
Identification of putative miRNA biomarkers in early rheumatoid arthritis by genome-wide microarray profiling: A pilot studyM F Romo-García, Y Bastian, M Zapata-Zuñiga, et al.Molecular Immunology|April 9, 2019
Structural variants of Salmonella Typhimurium lipopolysaccharide induce less dimerization of TLR4/MD-2 and reduced pro-inflammatory cytokine production in human monocytesGustavo Aldapa-Vega, Mario Adán Moreno-Eutimio, Antonio J Berlanga-Taylor, et al.Leukemia|November 11, 2005
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]G Perea, A Lasa, A Aventín, et al.Pageof 7